FDA approves new device for prevention of recurrent strokes in certain patients

fda.gov October 30, 2016

Amplatzer PFO Occluder

FDA approved the Amplatzer PFO Occluder device which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a small hole in the heart, called a patent foramen ovale (PFO), and then traveled to the brain.

catheter FDA stroke treatment

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

Sepsis Management: PIRO and MODS

Sepsis Management: PIRO and MODS

Understanding the Essentials of Critical Care Nursing

The COVID-19 Vaccine: An Expert’s Medical Guide for All

Hemodynamic Monitoring: Invasive and Noninvasive Clinical Application

The Beginner’s Guide to Intensive Care: A Handbook for Junior Doctors and Allied Professionals

Renal Failure and Replacement Therapies

Management of Severe Traumatic Brain Injury

Ventilator Management: A Pre-Hospital Perspective

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between